Product Information
AMITRIPTYLINE HCL 150 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2973 per EA under NDC 70710123001. Its NADAC has been published 407 times since Sep 12, 2018.
Strength
150 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710123001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210086On Market Since
12/26/2017
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 150 MG TAB has been published 407 times since Sep 12, 2018, and over the history we have for it it has declined 76.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2973 per EA |
|---|---|
| All-time high | $1.2771 (Sep 12, 2018) |
| All-time low | $0.1749 (Dec 21, 2022) |
| 52-week high | $0.2973 |
| 52-week low | $0.1953 |
| Median price | $0.3651 |
| Average price | $0.5357 |
| Largest weekly change | +55.6% (Mar 22, 2023) |
| Weeks tracked | 407 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 150 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2973 per EA (NDC 70710123001), effective Jun 24, 2026.
How has the price of AMITRIPTYLINE HCL 150 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has declined 76.7%. It has been tracked across 407 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 150 MG TAB?
Since Sep 12, 2018, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has ranged from a low of $0.1749 (Dec 21, 2022) to a high of $1.2771 (Sep 12, 2018), with a median of $0.3651 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 150 MG TAB?
8 NADAC-published products share the same active ingredient, strength, and dosage form as AMITRIPTYLINE HCL 150 MG TAB, but none are currently priced below it.
Who manufactures AMITRIPTYLINE HCL 150 MG TAB?
AMITRIPTYLINE HCL 150 MG TAB (NDC 70710123001) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification